RSS-Feed abonnieren
DOI: 10.1055/s-0040-1715594
Role of Transarterial Angiography with Embolization in Deciding Surgical Approach to Juvenile Nasopharyngeal Angiofibroma: A Step-Ladder Approach
Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Abstract
Objective This study was aimed to understand the usefulness of transarterial angiography and embolization in management of juvenile nasopharyngeal angiofibroma (JNA) and to apply the information obtained to stage the disease, select appropriate surgical approach, predict intraoperative bleeding, and prognosticate the disease.
Study Design This study represents a retrospective review of the patients of JNA with major focus on transarterial angiography and embolization findings and its clinical and surgical implications.
Setting The study conducted at a tertiary-care super-specialty referral center.
Participants Forty-two patients who had undergone transarterial angiography and embolization followed by surgery over the period of 5 years from July 2015 till February 2019 were participated in this study.
Main Outcome Measures Tumor vascular pattern based on transarterial angiography, staging of the disease based on extent and vascular supply, surgical approach selected, and prognosticating the disease were determined from this study.
Conclusion Transarterial angiography with embolization becomes a prudent preoperative investigation for management of JNA. It provides a complete three-dimensional map of the tumor with stage-specific vascular pattern, reduces vascularity of the tumor, and predicts the sites from where bleeding can occur intra operatively. Thus, it helps in choosing the appropriate surgical approach aiding in complete tumor removal with minimal bleeding.
Keywords
juvenile nasopharyngeal angiofibroma - transarterial angiography and embolization - stage-specific vascular pattern - surgical approach for JNAPublikationsverlauf
Eingereicht: 16. Februar 2020
Angenommen: 21. Juni 2020
Artikel online veröffentlicht:
20. August 2020
© 2020. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Nicolai P, Schreiber A, Bolzoni Villaret A. Juvenile angiofibroma: evolution of management. Int J Pediatr 2012; 2012: 412545
- 2 Gleeson M. Juvenile angiofibroma. In: Gleeson M. ed. Scott-Brown's Otorhinolaryngology, Head and Neck Surgery. 7th ed. London, United Kingdom: CRC Press; 2009
- 3 Snyderman CH, Pant H, Carrau RL, Gardner P. A new endoscopic staging system for angiofibromas. Arch Otolaryngol Head Neck Surg 2010; 136 (06) 588-594 Doi: 10.1001/archoto.2010.83
- 4 Chan KH, Gao D, Fernandez PG, Kingdom TT, Kumpe DA. Juvenile nasopharyngeal angiofibroma: vascular determinates for operative complications and tumor recurrence. Laryngoscope 2014; 124 (03) 672-677
- 5 Moulin G, Chagnaud C, Gras R. et al. Juvenile nasopharyngeal angiofibroma: comparison of blood loss during removal in embolized group versus nonembolized group. Cardiovasc Intervent Radiol. 1995; 18 (03) 158-161
- 6 Shah SR, Keshri A, Patadia S, Sahu RN, Srivastava AK, Behari S. Stage III nasopharyngeal angiofibroma: Improving results with endoscopic-assisted midfacial degloving and modification to the Fisch staging system. J Craniomaxillofac Surg 2015; 43 (08) 1678-1683
- 7 Tyagi I, Syal R, Goyal A. Recurrent and residual juvenile angiofibromas. J Laryngol Otol 2007; 121 (05) 460-467
- 8 Gross JB. Estimating allowable blood loss: corrected for dilution. Anesthesiology 1983; 58 (03) 277-280
- 9 Mishra A, Verma V. Implication of embolization in residual disease in lateral extension of juvenile nasopharyngeal angiofibroma. J Oral Biol Craniofac Res 2019; 9 (01) 115-118
- 10 Howard DJ, Lyod G, Lund V. Recurrence and its avoidance in juvenile angiofibroma. Laryngoscope 2001; 111 (09) 1509-1511
- 11 Thakar A, Hota A, Bhalla AS, Gupta SD, Sarkar C, Kumar R. Overt and occult vidian canal involvement in juvenile angiofibroma and its possible impact on recurrence. Head Neck 2016; 38 (Suppl. 01) E421-E425